Demerol (Meperidine) Market Report

China Demerol (Meperidine) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 20, 2022
  • PAGES：183
  • REPORT CODE：GMM1049543
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Demerol (meperidine), chemically known as ethyl 1-methyl-4-phenylisonipecotate hydrochloride, is an opioid pain medication. Meperidine is used to treat moderate-to-severe pain.An opioid is sometimes referred to as narcotics. Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Demerol (Meperidine) market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Demerol (Meperidine) market. Detailed analysis of key players, along with key growth strategies adopted by Demerol (Meperidine) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Boehringer Ingelheim

    • Mallinckrodt Pharmaceuticals

    • Sun Pharmaceuticals

    • Purdue Pharma

    • Endo Pharmaceuticals

    • Egalet

    • Pfizer

    • Janssen

    • Sanofi

    • Actavis

    By Type:

    • Powder

    • Liquid

    By End-User:

    • Anesthesia

    • Cough Treatment

    • Diarrhea Treatment

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Demerol (Meperidine) Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Demerol (Meperidine) Market Size and Growth Rate of Powder from 2016 to 2027

    • 1.3.2 China Demerol (Meperidine) Market Size and Growth Rate of Liquid from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Demerol (Meperidine) Market Size and Growth Rate of Anesthesia from 2016 to 2027

    • 1.4.2 China Demerol (Meperidine) Market Size and Growth Rate of Cough Treatment from 2016 to 2027

    • 1.4.3 China Demerol (Meperidine) Market Size and Growth Rate of Diarrhea Treatment from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Demerol (Meperidine) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Demerol (Meperidine) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Demerol (Meperidine) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Demerol (Meperidine) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Demerol (Meperidine) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Demerol (Meperidine) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Demerol (Meperidine) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Demerol (Meperidine) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Demerol (Meperidine) by Major Types

    • 3.4.1 Market Size and Growth Rate of Powder

    • 3.4.2 Market Size and Growth Rate of Liquid

    4 Segmentation of Demerol (Meperidine) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Demerol (Meperidine) by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Demerol (Meperidine) in Anesthesia

    • 4.4.2 Market Size and Growth Rate of Demerol (Meperidine) in Cough Treatment

    • 4.4.3 Market Size and Growth Rate of Demerol (Meperidine) in Diarrhea Treatment

    5 Market Analysis by Regions

    • 5.1 China Demerol (Meperidine) Production Analysis by Regions

    • 5.2 China Demerol (Meperidine) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Demerol (Meperidine) Landscape Analysis

    • 6.1 North China Demerol (Meperidine) Landscape Analysis by Major Types

    • 6.2 North China Demerol (Meperidine) Landscape Analysis by Major End-Users

    7 Central China Demerol (Meperidine) Landscape Analysis

    • 7.1 Central China Demerol (Meperidine) Landscape Analysis by Major Types

    • 7.2 Central China Demerol (Meperidine) Landscape Analysis by Major End-Users

    8 South China Demerol (Meperidine) Landscape Analysis

    • 8.1 South China Demerol (Meperidine) Landscape Analysis by Major Types

    • 8.2 South China Demerol (Meperidine) Landscape Analysis by Major End-Users

    9 East China Demerol (Meperidine) Landscape Analysis

    • 9.1 East China Demerol (Meperidine) Landscape Analysis by Major Types

    • 9.2 East China Demerol (Meperidine) Landscape Analysis by Major End-Users

    10 Northeast China Demerol (Meperidine) Landscape Analysis

    • 10.1 Northeast China Demerol (Meperidine) Landscape Analysis by Major Types

    • 10.2 Northeast China Demerol (Meperidine) Landscape Analysis by Major End-Users

    11 Southwest China Demerol (Meperidine) Landscape Analysis

    • 11.1 Southwest China Demerol (Meperidine) Landscape Analysis by Major Types

    • 11.2 Southwest China Demerol (Meperidine) Landscape Analysis by Major End-Users

    12 Northwest China Demerol (Meperidine) Landscape Analysis

    • 12.1 Northwest China Demerol (Meperidine) Landscape Analysis by Major Types

    • 12.2 Northwest China Demerol (Meperidine) Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Boehringer Ingelheim

      • 13.1.1 Boehringer Ingelheim Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Mallinckrodt Pharmaceuticals

      • 13.2.1 Mallinckrodt Pharmaceuticals Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Sun Pharmaceuticals

      • 13.3.1 Sun Pharmaceuticals Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Purdue Pharma

      • 13.4.1 Purdue Pharma Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Endo Pharmaceuticals

      • 13.5.1 Endo Pharmaceuticals Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Egalet

      • 13.6.1 Egalet Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Pfizer

      • 13.7.1 Pfizer Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Janssen

      • 13.8.1 Janssen Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Sanofi

      • 13.9.1 Sanofi Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Actavis

      • 13.10.1 Actavis Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Demerol (Meperidine) Market Size and Growth Rate of Powder from 2016 to 2027

    • Figure China Demerol (Meperidine) Market Size and Growth Rate of Liquid from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Demerol (Meperidine) Market Size and Growth Rate of Anesthesia from 2016 to 2027

    • Figure China Demerol (Meperidine) Market Size and Growth Rate of Cough Treatment from 2016 to 2027

    • Figure China Demerol (Meperidine) Market Size and Growth Rate of Diarrhea Treatment from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Demerol (Meperidine) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Demerol (Meperidine) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Demerol (Meperidine) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Demerol (Meperidine) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Demerol (Meperidine) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Demerol (Meperidine) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Demerol (Meperidine) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Demerol (Meperidine) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Demerol (Meperidine)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Demerol (Meperidine) by Different Types from 2016 to 2027

    • Table Consumption Share of Demerol (Meperidine) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Powder

    • Figure Market Size and Growth Rate of Liquid

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Demerol (Meperidine) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Demerol (Meperidine) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Anesthesia

    • Figure Market Size and Growth Rate of Cough Treatment

    • Figure Market Size and Growth Rate of Diarrhea Treatment

    • Table China Demerol (Meperidine) Production by Regions

    • Table China Demerol (Meperidine) Production Share by Regions

    • Figure China Demerol (Meperidine) Production Share by Regions in 2016

    • Figure China Demerol (Meperidine) Production Share by Regions in 2021

    • Figure China Demerol (Meperidine) Production Share by Regions in 2027

    • Table China Demerol (Meperidine) Consumption by Regions

    • Table China Demerol (Meperidine) Consumption Share by Regions

    • Figure China Demerol (Meperidine) Consumption Share by Regions in 2016

    • Figure China Demerol (Meperidine) Consumption Share by Regions in 2021

    • Figure China Demerol (Meperidine) Consumption Share by Regions in 2027

    • Table North China Demerol (Meperidine) Consumption by Types from 2016 to 2027

    • Table North China Demerol (Meperidine) Consumption Share by Types from 2016 to 2027

    • Figure North China Demerol (Meperidine) Consumption Share by Types in 2016

    • Figure North China Demerol (Meperidine) Consumption Share by Types in 2021

    • Figure North China Demerol (Meperidine) Consumption Share by Types in 2027

    • Table North China Demerol (Meperidine) Consumption by End-Users from 2016 to 2027

    • Table North China Demerol (Meperidine) Consumption Share by End-Users from 2016 to 2027

    • Figure North China Demerol (Meperidine) Consumption Share by End-Users in 2016

    • Figure North China Demerol (Meperidine) Consumption Share by End-Users in 2021

    • Figure North China Demerol (Meperidine) Consumption Share by End-Users in 2027

    • Table Central China Demerol (Meperidine) Consumption by Types from 2016 to 2027

    • Table Central China Demerol (Meperidine) Consumption Share by Types from 2016 to 2027

    • Figure Central China Demerol (Meperidine) Consumption Share by Types in 2016

    • Figure Central China Demerol (Meperidine) Consumption Share by Types in 2021

    • Figure Central China Demerol (Meperidine) Consumption Share by Types in 2027

    • Table Central China Demerol (Meperidine) Consumption by End-Users from 2016 to 2027

    • Table Central China Demerol (Meperidine) Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Demerol (Meperidine) Consumption Share by End-Users in 2016

    • Figure Central China Demerol (Meperidine) Consumption Share by End-Users in 2021

    • Figure Central China Demerol (Meperidine) Consumption Share by End-Users in 2027

    • Table South China Demerol (Meperidine) Consumption by Types from 2016 to 2027

    • Table South China Demerol (Meperidine) Consumption Share by Types from 2016 to 2027

    • Figure South China Demerol (Meperidine) Consumption Share by Types in 2016

    • Figure South China Demerol (Meperidine) Consumption Share by Types in 2021

    • Figure South China Demerol (Meperidine) Consumption Share by Types in 2027

    • Table South China Demerol (Meperidine) Consumption by End-Users from 2016 to 2027

    • Table South China Demerol (Meperidine) Consumption Share by End-Users from 2016 to 2027

    • Figure South China Demerol (Meperidine) Consumption Share by End-Users in 2016

    • Figure South China Demerol (Meperidine) Consumption Share by End-Users in 2021

    • Figure South China Demerol (Meperidine) Consumption Share by End-Users in 2027

    • Table East China Demerol (Meperidine) Consumption by Types from 2016 to 2027

    • Table East China Demerol (Meperidine) Consumption Share by Types from 2016 to 2027

    • Figure East China Demerol (Meperidine) Consumption Share by Types in 2016

    • Figure East China Demerol (Meperidine) Consumption Share by Types in 2021

    • Figure East China Demerol (Meperidine) Consumption Share by Types in 2027

    • Table East China Demerol (Meperidine) Consumption by End-Users from 2016 to 2027

    • Table East China Demerol (Meperidine) Consumption Share by End-Users from 2016 to 2027

    • Figure East China Demerol (Meperidine) Consumption Share by End-Users in 2016

    • Figure East China Demerol (Meperidine) Consumption Share by End-Users in 2021

    • Figure East China Demerol (Meperidine) Consumption Share by End-Users in 2027

    • Table Northeast China Demerol (Meperidine) Consumption by Types from 2016 to 2027

    • Table Northeast China Demerol (Meperidine) Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Demerol (Meperidine) Consumption Share by Types in 2016

    • Figure Northeast China Demerol (Meperidine) Consumption Share by Types in 2021

    • Figure Northeast China Demerol (Meperidine) Consumption Share by Types in 2027

    • Table Northeast China Demerol (Meperidine) Consumption by End-Users from 2016 to 2027

    • Table Northeast China Demerol (Meperidine) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Demerol (Meperidine) Consumption Share by End-Users in 2016

    • Figure Northeast China Demerol (Meperidine) Consumption Share by End-Users in 2021

    • Figure Northeast China Demerol (Meperidine) Consumption Share by End-Users in 2027

    • Table Southwest China Demerol (Meperidine) Consumption by Types from 2016 to 2027

    • Table Southwest China Demerol (Meperidine) Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Demerol (Meperidine) Consumption Share by Types in 2016

    • Figure Southwest China Demerol (Meperidine) Consumption Share by Types in 2021

    • Figure Southwest China Demerol (Meperidine) Consumption Share by Types in 2027

    • Table Southwest China Demerol (Meperidine) Consumption by End-Users from 2016 to 2027

    • Table Southwest China Demerol (Meperidine) Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Demerol (Meperidine) Consumption Share by End-Users in 2016

    • Figure Southwest China Demerol (Meperidine) Consumption Share by End-Users in 2021

    • Figure Southwest China Demerol (Meperidine) Consumption Share by End-Users in 2027

    • Table Northwest China Demerol (Meperidine) Consumption by Types from 2016 to 2027

    • Table Northwest China Demerol (Meperidine) Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Demerol (Meperidine) Consumption Share by Types in 2016

    • Figure Northwest China Demerol (Meperidine) Consumption Share by Types in 2021

    • Figure Northwest China Demerol (Meperidine) Consumption Share by Types in 2027

    • Table Northwest China Demerol (Meperidine) Consumption by End-Users from 2016 to 2027

    • Table Northwest China Demerol (Meperidine) Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Demerol (Meperidine) Consumption Share by End-Users in 2016

    • Figure Northwest China Demerol (Meperidine) Consumption Share by End-Users in 2021

    • Figure Northwest China Demerol (Meperidine) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Mallinckrodt Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Mallinckrodt Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Mallinckrodt Pharmaceuticals

    • Table Product and Service Introduction of Mallinckrodt Pharmaceuticals

    • Table Company Profile and Development Status of Sun Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Sun Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Sun Pharmaceuticals

    • Table Product and Service Introduction of Sun Pharmaceuticals

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

    • Table Company Profile and Development Status of Endo Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Endo Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Endo Pharmaceuticals

    • Table Product and Service Introduction of Endo Pharmaceuticals

    • Table Company Profile and Development Status of Egalet

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Egalet

    • Figure Sales and Growth Rate Analysis of Egalet

    • Figure Revenue and Market Share Analysis of Egalet

    • Table Product and Service Introduction of Egalet

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Janssen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen

    • Figure Sales and Growth Rate Analysis of Janssen

    • Figure Revenue and Market Share Analysis of Janssen

    • Table Product and Service Introduction of Janssen

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Actavis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis

    • Figure Sales and Growth Rate Analysis of Actavis

    • Figure Revenue and Market Share Analysis of Actavis

    • Table Product and Service Introduction of Actavis


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US